Digest Gold + Probiotics
Natural health product licensed in Canada
- Licence holder
- Enzymedica Inc.
- NPN or DIN-HM
- 80040285
- Status
- Active licence
- Licence date
- 25 February 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisae | 79 FCC INVU | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisae | 1 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger | 50 FCC AGU | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger | 50 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae | 3,500 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger | 3,500 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae | 24 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger | 24 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Aspergillus flavus var. oryzae | 23,000 FCC DU | Not calculated |
| Bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae | 900 FCC ALU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger | 450 FCC GalU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger | 3,000 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger | 30 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei | 3,000 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei | 30 mg | Not calculated |
| Poly(1-4-a-D-galacturonide)glycanohydrolase Source : Aspergillus niger | 45 Endo-PGU | Not calculated |
| Poly(1-4-a-D-galacturonide)glycanohydrolase Source : Aspergillus niger | 1 mg | Not calculated |
| Lactobacillus casei Source : Cellule entière (vivant) | 139 Millions d'UFC | Not calculated |
| Lactobacillus casei Source : ATCC SD5213 | 139 Millions d'UFC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis | 2,684 FCC PC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis | 9 mg | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 200 FCC DP | Not calculated |
Non-medicinal ingredients
cellulose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzymes. Helps digest proteins. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables/pulses/legumes and whole grains). Provides live microorganisms that temporarily modify gut flora. Source of probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80040285
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.